Valereum PLC - Binding Heads of Terms for £19m Capital Raise
Announcement provided by
Valereum Plc · VLRM20/02/2025 07:52

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
20/02/25
Valereum Plc
("VLRM" or the "Company")
Valereum Plc enters into Binding Heads Of Terms for a Capital Raise of
Four Strategic Investments and
A Further
Valereum Plc (AQSE: VLRM) is pleased to announce that it has entered into a binding Heads of Terms ("HoT") for a
The HoT signed by the parties, as being announced today, contain different terms from the announcement made on 16 December 2024. Notably, DMC via Valereum Inc. will now subscribe for a total of shares worth
DMC's
Valereum Plc has agreed to issue Valereum Inc. a total of 170,000,000 ordinary shares in the capital of the Company (the "Subscription Shares"), allocated as follows:
- 130,000,000 ordinary shares at an issue price of
- 20,000,000 ordinary shares at an issue price of
- DMC Markets Inc., via its entity, Valereum Inc. will acquire 20,000,000 ordinary shares at an issue price of
The proceeds of the Investment will be used to make four strategic investments, to provide working capital to support the investments and Valereum Plc's growth plans, and to fund and accelerate the rollout of its tokenisation and digital asset services.
Strategic Asset Investments
Part of the proceeds of the Investment will fund the acquisition of minority interests in four complementary strategic assets which have been sourced by DMC ("Strategic Investments"). Upon completion of the Strategic Investments, Valereum Plc will have greater presence across
Institutional Investor
Valereum Plc also announces the successful capital raise of an additional
Admission of Shares
The Subscription Shares to be issued to DMC via Valereum Inc. and the institutional investor are expected to be admitted to trading on AQSE on or around 04 March 2025, subject to completion of the necessary issuance procedures.
To discover more and for the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub. Here you will find company news and additional content to further explain Valereum Plc's strategy and products.
For further information, please contact:
Valereum Plc Peter Sekhon, Investor Relation Director Engage with the company directly |
Tel: +44 7938 767319 |
Stanford Capital Partners Bob Pountney/ Patrick Claridge |
Tel: +44 023 3650 3650 |
AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge / Gabrielle Cordeiro |
Tel: +44 20 3855 5551 |
The Directors of the Company accept responsibility for the contents of this announcement.
Please visit the Company's website at www.vlrm.com or to engage with the Valereum Plc management team directly by asking questions, watching video summaries and seeing what other shareholders have to say:
Navigate to our Interactive Investor hub here: Sign Up
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.